A Study to Evaluate the Safety and Tolerability of ABBV-951 in Subjects With Parkinson's Disease (PD)

NCT03781167 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
244
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

AbbVie